Dose and route of administration of N-acetylcysteine are key factors to consider when evaluating whether this agent is effective in preventing radiocontrast induced nephropathy
- NAC, N-acetylcysteine
- RCIN, radiocontrast induced nephropathy
- contrast nephrotoxicity
- route of administration
Statistics from Altmetric.com
↵* Also at the Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada
Competing interest statement: There are no grants, business interests, or consultancies that could lead to a conflict of interest.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.